Eric Marandett on Recent Decision That May Impact Drug Patents in Law360

IP Law360

 | December 6, 2013

 | Eric Marandett

View "How Federal Circuit's Commil Ruling Could Affect Drug Patents"


Eric Marandett  co-wrote “How Federal Circuit’s Commil Ruling Could Affect Drug Patents” in IP Law360, where he discusses a recent decision that has made it more difficult for patentees to prove induced infringement, which may weaken method of treatment, mechanism of action and method of manufacturing patents held by life sciences companies.  This also appeared in the Life Sciences and Appellate sections of Law360


Thank you for reaching out to contact Choate. Before you send your message, we wanted to make sure you are aware of the following. Please do not send any confidential information in response to this link. Sending an e-mail to Choate does not give rise to an attorney-client relationship, and will not be deemed to disqualify Choate from undertaking any engagement for a current or future client.  Before any attorney-client engagement may be formed, Choate will need to check for possible conflicts of interest, you will need to consider whether you wish to retain Choate as counsel, and we will need to consider whether we wish to accept the potential engagement. In the meantime, Choate reserves the right to represent parties with interests adverse to you.